New Age Alpha Advisors, LLC Gilead Sciences, Inc. Transaction History
New Age Alpha Advisors, LLC
- $2.47 Trillion
- Q4 2024
A detailed history of New Age Alpha Advisors, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, New Age Alpha Advisors, LLC holds 116,686 shares of GILD stock, worth $12.4 Million. This represents 0.44% of its overall portfolio holdings.
Number of Shares
116,686Holding current value
$12.4 Million% of portfolio
0.44%Shares
1 transactions
Others Institutions Holding GILD
# of Institutions
2,045Shares Held
1BCall Options Held
10MPut Options Held
9.05M-
Black Rock Inc. New York, NY121MShares$12.8 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$12.2 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$7.6 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.4 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.14 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $133B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...